NLS Editor's Pick

Sweden's industries have long been celebrated for their innovation and impact, but the life sciences stand out for their remarkable achievements that are unfortunately less visible to the public eye. In this article, Maja Neiman from SwedenBIO explores how we can better showcase these groundbreaking advancements to a broader audience.

FinVector has emerged as a pioneer in the manufacturing of viral-based gene therapy. The company is this year’s BioFinland Award winner and NLS asked Matthias Krieger, Managing Director, about milestones, gene therapy, and not least, the importance of teamwork.

Fertram Sigurjonsson's company Kerecis is dedicated to producing and commercializing fish skin for medical purposes. Recently, the company became one of Iceland’s first unicorns when it was acquired by Danish medtech giant Coloplast.

Malin Parmar, professor and research team leader at Developmental and Regenerative Neurobiology, Lund University, has spent over a decade working with stem cells to produce dopamine as a treatment for Parkinson's disease. After such a dedicated effort, some patients are now participating in clinical trials for stem-cell-based transplants.

This summer, the Swedish-Danish project DiaUnion, which aims to prevent type 1 diabetes, launched a pioneering screening program – taking this unique cross-border collaboration to the next level.